For each citation that was shared on social media (LinkedIn, Facebook, or Twitter) with the “@GenScript” tag, the author will be rewarded with a $10 Amazon gift card or 2,000 GS points.

PD-1 Signaling Promotes Control of Chronic Viral Infection by Restricting Type-I-Interferon-Mediated Tissue Damage

Cell Rep.. 2019; 
Raju S1, Verbaro DJ1, Egawa T2.
Products/Services Used Details Operation
Peptide Synthesis … H2-Db(LCMV gp276-284) tetramer, MBL International, CAT#TB-5009-1. Fetal Bovine Serum,<br> Thermofisher, CAT#10437028. LCMV gp276-284 peptide, <b>Genscript</b>, CAT#RP19983. LCMV<br> gp33-41 peptide, <b>Genscript</b>, CAT#RP20257. Linear Acrylamide, Ambion, CAT#AM9520 … Get A Quote

Abstract

Immune responses are essential for pathogen elimination but also cause tissue damage, leading to disease or death. However, it is unclear how the host immune system balances control of infection and protection from the collateral tissue damage. Here, we show that PD-1-mediated restriction of immune responses is essential for durable control of chronic LCMV infection in mice. In contrast to responses in the chronic phase, PD-1 blockade in the subacute phase of infection paradoxically results in viral persistence. This effect is associated with damage to lymphoid architecture and subsequently decreases adaptive immune responses. Moreover, this tissue damage is type I interferon dependent, as sequential blockade o... More

Keywords